Your browser doesn't support javascript.
loading
Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain.
Maschauer, Simone; Haller, Adelina; Riss, Patrick J; Kuwert, Torsten; Prante, Olaf; Cumming, Paul.
Afiliación
  • Maschauer S; Laboratory of Molecular Imaging and Radiochemistry, Department of Nuclear Medicine, Friedrich Alexander University, Erlangen, Germany.
  • Haller A; Laboratory of Molecular Imaging and Radiochemistry, Department of Nuclear Medicine, Friedrich Alexander University, Erlangen, Germany.
  • Riss PJ; Department of Chemistry, Universitetet i Oslo & Norsk Medisinisk Syklotronsenter AS, Oslo, Norway.
  • Kuwert T; Laboratory of Molecular Imaging and Radiochemistry, Department of Nuclear Medicine, Friedrich Alexander University, Erlangen, Germany.
  • Prante O; Laboratory of Molecular Imaging and Radiochemistry, Department of Nuclear Medicine, Friedrich Alexander University, Erlangen, Germany.
  • Cumming P; Department of Neuroscience and Pharmacology, Copenhagen University, Copenhagen, Denmark.
J Neurochem ; 135(5): 908-17, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26386360
We investigated [(18)F]fluoroethyl-harmol ([(18)F]FEH) as a reversible and selective ligand for positron emission tomography (PET) studies of monoamine oxidase A (MAO-A). Binding of [(18)F]FEH in rat brain cryostat sections indicated high affinity (KD = 3 nM), and density (Bmax; 600 pmol/g). The plasma free fraction was 45%, and untransformed parent constituted only 13% of plasma radioactivity at 10 min after injection. Compartmental analysis of PET recordings in pargyline-treated rats showed high permeability to brain (K1; 0.32 mL/g/min) and slow washout (k2; 0.024/min), resulting in a uniformly high equilibrium distribution volume (VD; 20 mL/g). Using this VD to estimate unbound ligand in brain of untreated rats, the binding potential ranged from 4.2 in cerebellum to 7.2 in thalamus. We also calculated maps of rats receiving [(18)F]FEH at a range of specific activities, and then estimated saturation binding parameters in the living brain. In thalamus, striatum and frontal cortex KD was globally close to 300 nM and Bmax was close to 1600 pmol/g; the 100-fold discrepancy in affinity suggests a very low free fraction for [(18)F]FEH in the living brain. Based on a synthesis of findings, we calculate the endogenous dopamine concentration to be 0.4 µM in the striatal compartment containing MAO-A, thus unlikely to exert competition against [(18)F]FEH binding in vivo. In summary, [(18)F]FEH has good properties for the detection of MAO-A in the rat brain by PET, and may present logistic advantages for clinical research at centers lacking a medical cyclotron. We made a compartmental analysis of [(18)F]fluoroethylharmol ([(18)F]FEH) binding to monoamine oxidase A (MAO-A) in living rat brain and estimated the saturation binding parameters from the binding potential (BPND). The Bmax was of comparable magnitude to that in vitro, but with apparent affinity (300 nM), it was 100-fold lower in vivo. PET imaging with [(18) F]FEH is well suited for quantitation of MAO-A in living brain.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Harmina / Monoaminooxidasa / Inhibidores de la Monoaminooxidasa Límite: Animals Idioma: En Revista: J Neurochem Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Harmina / Monoaminooxidasa / Inhibidores de la Monoaminooxidasa Límite: Animals Idioma: En Revista: J Neurochem Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido